JulianRMolinaMD

Clinical Trials

• R115777 in Treating Patients With Recurrent or Metastatic Non-small Cell Lung Cancer Start of enrollment: 2002 Nov 01

  Completed

  Phase 2

• Tipifarnib and Erlotinib Hydrochloride in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 May 20

  Completed

  Phase 1

• Sorafenib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2004 Dec 01

  Completed

  Phase 2

• Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2006 Feb 01

  Completed

  Phase 2

• Vatalanib and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors Start of enrollment: 2007 Jan 25

  Completed

  Phase 1

• Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer Start of enrollment: 2006 Nov 01

  Completed

  Phase 2

• Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer Start of enrollment: 2007 Jan 25

  Completed

  Phase 1

• Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer Start of enrollment: 2003 Apr 01

  Completed

  Phase 2

• Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 Dec 01

  Completed

  Phase 1

• Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524 Start of enrollment: 2006 Nov 01

  Completed

• Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer Start of enrollment: 2010 Jan 01

  Terminated

  Phase 2

• Pemetrexed Disodium/Observation in Treating Patients W/ Malignant Pleural Mesothelioma w/Out Progressive Disease After 1st Line Chemotherapy Start of enrollment: 2010 Apr 01

  Completed

  Phase 2

• Weekly Doses of Cilengitide and Paclitaxel in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery Start of enrollment: 2010 Dec 01

  Completed

  Phase 1

• A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01

  Completed

  Phase 1, Phase 2

• Validation of the MiCK Assay Start of enrollment: 2012 Jun 01

  Terminated

• A Study of Emibetuzumab in Non Small Cell Lung Cancer (NSCLC) Participants Start of enrollment: 2013 Aug 01

  Completed

  Phase 2

• Expanded Treatment Protocol With LDK378 in ALK(+) NSCLC

  No longer available

• Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy Start of enrollment: 2015 Jun 29

  Terminated

  Phase 2

• Lung-MAP: Taselisib as Therapy in Treating Patients With Stage IV Squamous Cell Lung Cancer and Positive Biomarker Matches Start of enrollment: 2014 Nov 01

  Completed

  Phase 2

• Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer Start of enrollment: 2014 Sep 01

  Completed

  Phase 2, Phase 3

• Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers Start of enrollment: 2015 Dec 29

  Active, not recruiting

  Phase 3

• Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing Start of enrollment: 2021 Oct 29

  Recruiting

• Join now to see all